The global Placenta market size was valued at US$ 81.9 million in 2024 and is forecast to a readjusted size of USD 135 million by 2031 with a CAGR of 7.5% during review period.
Placenta is the vascular organ in most mammals that connects the fetus to the uterus of the mother. It mediates the metabolic exchanges of the developing individual through an intimate association of embryonic tissues and of specific uterine tissues, which serve the functions of respiration, nutrition, and excretion. Placentas are also used as a source of extracts for ingredients in various consumer products.
The growing interest in the therapeutic and cosmetic applications of placental products is a significant driver of the placenta market. Placenta-based products are increasingly used in skincare for their anti-aging and regenerative properties, as well as in pharmaceuticals for wound healing, tissue repair, and immune system support. The rising awareness of the potential health benefits of placental extracts, combined with advancements in biotechnology and stem cell research, is fueling demand across various industries, including cosmetics, healthcare, and nutraceuticals.
A key challenge in the placenta market is the ethical concerns and regulatory complexities surrounding the sourcing and use of human or animal placental tissues. Strict regulations govern the collection, processing, and commercialization of placenta-derived products, particularly in regions with stringent ethical standards. Additionally, ensuring the safety, quality, and consistency of these products can be difficult, as variations in sourcing and processing methods may affect efficacy. These factors can limit market growth, particularly in regions with tight regulatory oversight.
Japan is the largest consumption place, with a consumption market share nearly 36%. Following Japan, Europe is the second largest consumption place with the consumption market share of 15%. 麻豆原创 competition is intense. Japan Bio Products, Charites Japan, Japan Natural Laboratories, Bovogen Biologicals, Thimba Li, Agri-Lab Co-Products, etc. The top 3 vendors held 30% of the market, in terms of placenta revenue.The classification of placenta includes ovine, porcine, equine and others. Ovine accounted for a share of 45% in the global placenta market.
This report is a detailed and comprehensive analysis for global Placenta market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Placenta market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2020-2031
Global Placenta market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2020-2031
Global Placenta market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2020-2031
Global Placenta market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Placenta
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Placenta market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Japan Bio Products, Charites Japan, Japan Natural Laboratories, Bovogen Biologicals, Thimba Li, Agri-Lab Co-Products, Yinchuan Yibaisheng, BIOFAC, Hokkaido Natural Bio Group, Shaanxi Jintai Biological Engineering, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Placenta market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Ovine
Porcine
Equine
Others
麻豆原创 segment by Application
Cosmetics
Health Tonics
Other
Major players covered
Japan Bio Products
Charites Japan
Japan Natural Laboratories
Bovogen Biologicals
Thimba Li
Agri-Lab Co-Products
Yinchuan Yibaisheng
BIOFAC
Hokkaido Natural Bio Group
Shaanxi Jintai Biological Engineering
Genesis Biolaboratory
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Placenta product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Placenta, with price, sales quantity, revenue, and global market share of Placenta from 2020 to 2025.
Chapter 3, the Placenta competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Placenta breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Placenta market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Placenta.
Chapter 14 and 15, to describe Placenta sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Placenta Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Ovine
1.3.3 Porcine
1.3.4 Equine
1.3.5 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Placenta Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Cosmetics
1.4.3 Health Tonics
1.4.4 Other
1.5 Global Placenta 麻豆原创 Size & Forecast
1.5.1 Global Placenta Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Placenta Sales Quantity (2020-2031)
1.5.3 Global Placenta Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Japan Bio Products
2.1.1 Japan Bio Products Details
2.1.2 Japan Bio Products Major Business
2.1.3 Japan Bio Products Placenta Product and Services
2.1.4 Japan Bio Products Placenta Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Japan Bio Products Recent Developments/Updates
2.2 Charites Japan
2.2.1 Charites Japan Details
2.2.2 Charites Japan Major Business
2.2.3 Charites Japan Placenta Product and Services
2.2.4 Charites Japan Placenta Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Charites Japan Recent Developments/Updates
2.3 Japan Natural Laboratories
2.3.1 Japan Natural Laboratories Details
2.3.2 Japan Natural Laboratories Major Business
2.3.3 Japan Natural Laboratories Placenta Product and Services
2.3.4 Japan Natural Laboratories Placenta Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Japan Natural Laboratories Recent Developments/Updates
2.4 Bovogen Biologicals
2.4.1 Bovogen Biologicals Details
2.4.2 Bovogen Biologicals Major Business
2.4.3 Bovogen Biologicals Placenta Product and Services
2.4.4 Bovogen Biologicals Placenta Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Bovogen Biologicals Recent Developments/Updates
2.5 Thimba Li
2.5.1 Thimba Li Details
2.5.2 Thimba Li Major Business
2.5.3 Thimba Li Placenta Product and Services
2.5.4 Thimba Li Placenta Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Thimba Li Recent Developments/Updates
2.6 Agri-Lab Co-Products
2.6.1 Agri-Lab Co-Products Details
2.6.2 Agri-Lab Co-Products Major Business
2.6.3 Agri-Lab Co-Products Placenta Product and Services
2.6.4 Agri-Lab Co-Products Placenta Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Agri-Lab Co-Products Recent Developments/Updates
2.7 Yinchuan Yibaisheng
2.7.1 Yinchuan Yibaisheng Details
2.7.2 Yinchuan Yibaisheng Major Business
2.7.3 Yinchuan Yibaisheng Placenta Product and Services
2.7.4 Yinchuan Yibaisheng Placenta Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Yinchuan Yibaisheng Recent Developments/Updates
2.8 BIOFAC
2.8.1 BIOFAC Details
2.8.2 BIOFAC Major Business
2.8.3 BIOFAC Placenta Product and Services
2.8.4 BIOFAC Placenta Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 BIOFAC Recent Developments/Updates
2.9 Hokkaido Natural Bio Group
2.9.1 Hokkaido Natural Bio Group Details
2.9.2 Hokkaido Natural Bio Group Major Business
2.9.3 Hokkaido Natural Bio Group Placenta Product and Services
2.9.4 Hokkaido Natural Bio Group Placenta Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Hokkaido Natural Bio Group Recent Developments/Updates
2.10 Shaanxi Jintai Biological Engineering
2.10.1 Shaanxi Jintai Biological Engineering Details
2.10.2 Shaanxi Jintai Biological Engineering Major Business
2.10.3 Shaanxi Jintai Biological Engineering Placenta Product and Services
2.10.4 Shaanxi Jintai Biological Engineering Placenta Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Shaanxi Jintai Biological Engineering Recent Developments/Updates
2.11 Genesis Biolaboratory
2.11.1 Genesis Biolaboratory Details
2.11.2 Genesis Biolaboratory Major Business
2.11.3 Genesis Biolaboratory Placenta Product and Services
2.11.4 Genesis Biolaboratory Placenta Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Genesis Biolaboratory Recent Developments/Updates
3 Competitive Environment: Placenta by Manufacturer
3.1 Global Placenta Sales Quantity by Manufacturer (2020-2025)
3.2 Global Placenta Revenue by Manufacturer (2020-2025)
3.3 Global Placenta Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Placenta by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Placenta Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Placenta Manufacturer 麻豆原创 Share in 2024
3.5 Placenta 麻豆原创: Overall Company Footprint Analysis
3.5.1 Placenta 麻豆原创: Region Footprint
3.5.2 Placenta 麻豆原创: Company Product Type Footprint
3.5.3 Placenta 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Placenta 麻豆原创 Size by Region
4.1.1 Global Placenta Sales Quantity by Region (2020-2031)
4.1.2 Global Placenta Consumption Value by Region (2020-2031)
4.1.3 Global Placenta Average Price by Region (2020-2031)
4.2 North America Placenta Consumption Value (2020-2031)
4.3 Europe Placenta Consumption Value (2020-2031)
4.4 Asia-Pacific Placenta Consumption Value (2020-2031)
4.5 South America Placenta Consumption Value (2020-2031)
4.6 Middle East & Africa Placenta Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Placenta Sales Quantity by Type (2020-2031)
5.2 Global Placenta Consumption Value by Type (2020-2031)
5.3 Global Placenta Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Placenta Sales Quantity by Application (2020-2031)
6.2 Global Placenta Consumption Value by Application (2020-2031)
6.3 Global Placenta Average Price by Application (2020-2031)
7 North America
7.1 North America Placenta Sales Quantity by Type (2020-2031)
7.2 North America Placenta Sales Quantity by Application (2020-2031)
7.3 North America Placenta 麻豆原创 Size by Country
7.3.1 North America Placenta Sales Quantity by Country (2020-2031)
7.3.2 North America Placenta Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Placenta Sales Quantity by Type (2020-2031)
8.2 Europe Placenta Sales Quantity by Application (2020-2031)
8.3 Europe Placenta 麻豆原创 Size by Country
8.3.1 Europe Placenta Sales Quantity by Country (2020-2031)
8.3.2 Europe Placenta Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Placenta Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Placenta Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Placenta 麻豆原创 Size by Region
9.3.1 Asia-Pacific Placenta Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Placenta Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Placenta Sales Quantity by Type (2020-2031)
10.2 South America Placenta Sales Quantity by Application (2020-2031)
10.3 South America Placenta 麻豆原创 Size by Country
10.3.1 South America Placenta Sales Quantity by Country (2020-2031)
10.3.2 South America Placenta Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Placenta Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Placenta Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Placenta 麻豆原创 Size by Country
11.3.1 Middle East & Africa Placenta Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Placenta Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Placenta 麻豆原创 Drivers
12.2 Placenta 麻豆原创 Restraints
12.3 Placenta Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Placenta and Key Manufacturers
13.2 Manufacturing Costs Percentage of Placenta
13.3 Placenta Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Placenta Typical Distributors
14.3 Placenta Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Japan Bio Products
Charites Japan
Japan Natural Laboratories
Bovogen Biologicals
Thimba Li
Agri-Lab Co-Products
Yinchuan Yibaisheng
BIOFAC
Hokkaido Natural Bio Group
Shaanxi Jintai Biological Engineering
Genesis Biolaboratory
听
听
*If Applicable.
